ESTEBAN PALACIOS: Open Payments
NPI 1508010075 · SAN JUAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,556 in 112 payments from 19 companies in 2025. Trend: 2023 $2,228 · 2024 $3,574 · 2025 $4,556
Food & beverage: $4,485Entertainment: $71
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $540 |
| AstraZeneca Pharmaceuticals LP | 11 | $534 |
| Novo Nordisk Inc | 23 | $508 |
| Lilly USA, LLC | 11 | $485 |
| Medtronic, Inc. | 9 | $449 |
| Dexcom, Inc. | 5 | $418 |
| Amgen Inc. | 15 | $382 |
| Optinose US, Inc. | 7 | $234 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $167 |
| Boston Scientific Corporation | 2 | $137 |
Products named: FREESTYLE LIBRE, AIRSUPRA, SYNCHROMEDII, Dexcom G6 Transmitter, REPATHA, Xhance, Wegovy, JARDIANCE.
Industry payments across TX — which companies pay providers there.
